Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Genmab

Clinical trials sponsored by Genmab, explained in plain language.

Genmab GMAB NASDAQ

Biotechnology company specializing in antibody therapeutics for cancer and other diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 11 Not yet recruiting 1 Not yet finished but already full! 16 Completed 1 Terminated 12
Sort by
  • New drug GEN1119 aims to fight solid tumors that resist standard care

    Disease control Not yet recruiting

    This trial investigates a new drug called GEN1119 for people with certain solid tumors that have not improved with standard treatments or for whom no standard treatment exists. The study is divided into parts: first, to find safe and effective doses, then to test those doses in m…

    Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control

    Last updated Aug 06, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space